Magnetic Group Signaling (MGS®) standardizes NMR systems and sample processing to ensure reproducible results on different NMR instruments.
Advanced. Automated. Affordable. Mastering Metabolite Networks for Real-Time Precision Medicine.
Learn more
AXINON® is the first modular software-based system providing hardware, operating system, MGS® processor and individual test applications.
Locations: Boston, MA;
Regensburg, GE
employees of medical and
scientific disciplines
Founded as a spin-off of
Regensburg University
analyses worldwide with numares
technology
We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that cannot be addressed by single biomarker-based medicine.
numares has developed a versatile platform technology for developing innovative diagnostic tests based on the differences in the metabolism of people with and without a particular disease.
Our diagnostic tests are based on the interpretation of biomarker in the metabolism, whose dynamics and relation to each other allow for predicting disease progression. These metabolite constellations create diagnostics of a new generation: non-invasive, timely and meaningful at manageable costs.
- Chairman of the Supervisory Board
- Co-founder & Partner of SHS Capital
- Previously with McKinsey
- Managing Director of Mayfair SE
- Previously board member at Tchibo
- Supervisory board member at Puma
- Senior Director at Mayo Clinic
- Steering committee member of numares-Mayo collaboration
- Previously with Oncospire Genetics, & Roche
- Founder & CEO of DiaMedCare
- Previously with Novartis Ciba Geigy
- Previously with McKinsey
- Scientific Advisory Board of Everly Health
- Strategic & scientific advisor
- Previously with Roche & Illumina